Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Inactivated Sendai Virus Strain Tianjin Induces Apoptosis in Human Breast Cancer MDA-MB-231 Cells

  • Chen, Jun (Department of Microbiology, Basic Medical College, Tianjin Medical University) ;
  • Han, Han (Department of Microbiology, Basic Medical College, Tianjin Medical University) ;
  • Chen, Min (Department of Nursing, The 44th Hospital of PLA) ;
  • Xu, Xiao-Zhu (The Second People Hospital of Guizhou Province) ;
  • Wang, Bin (Department of Anesthesiology, Tianjin Research Institute of Anesthesiology, Tianjin Medical University General Hospital) ;
  • Shi, Li-Ying (Department of Microbiology, Basic Medical College, Tianjin Medical University)
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Sendai virus strain Tianjin is a novel genotype. Here, we investigate the antitumor and proapoptotic effects of ultraviolet-inactivated Sendai virus strain Tianjin (UV-Tianjin) on human breast cancer MDA-MB-231 cells in vitro, as well as the involvement of the apoptotic pathway in the mechanism of UV-Tianjin-induced antitumor effects. MTT assays showed that treatment with UV-Tianjin dose-dependently inhibited the proliferation of MDA-MB-231 cells but not normal MCF 10A breast epithelium cells. Hoechst staining and flow cytometric analysis revealed that UV-Tianjin induced apoptosis of MDA-MB-231 cells in a dose-dependent manner. Moreover, UV-Tianjin treatment resulted in reduction in the mitochondria membrane potential (MMP) and release of cytochrome complex (cyt c) via regulation of Bax and Bcl-2, as well as activation of caspase-9, caspase-3, Fas, FasL and caspase-8 in MDA-MB-231 cells. In summary, our study suggests that UV-Tianjin exhibits anticancer activity in human breast cancer MDA-MB-231 cells through inducing apoptosis, which may involve both the endogenous mitochondrial and exogenous death receptor pathways.

Keywords

References

  1. Bi MC, Rosen R, Zha RY, et al (2013). Zeaxanthin induces apoptosis in human uveal melanoma cells through Bcl-2 family proteins and intrinsic apoptosis pathway. Evid Based Complement Alternat Med, 2013, 205082.
  2. Danial NN, Korsmeyer SJ (2004). Cell death: critical control points. Cell, 116, 205-19. https://doi.org/10.1016/S0092-8674(04)00046-7
  3. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN (2007). Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol, 608, 1-22. https://doi.org/10.1007/978-0-387-74039-3_1
  4. Gu TW, Bae WY, Park HT, et al (2014). Expression profile of fas-fas ligand in spiral ganglion cells during apoptosis. Clin Exp Otorhinolaryngol, 7, 1-6. https://doi.org/10.3342/ceo.2014.7.1.1
  5. Han Z, Zhou HJ, Zhao J, et al (2013). Study on apoptosis of rat glioma cells induced by defective interfering particles of Sendai virus strain Tianjin. Chin J Microbiol Immunol, 33, 677-82.
  6. He D, Sun L, Li C, et al (2014). Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo. Viruses, 6, 856-74. https://doi.org/10.3390/v6020856
  7. Hiraoka K, Yamamoto S, Otsuru S, et al (2004). Enhanced tumorspecific long-term immunity of hemagglutinating virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides. J Immunol, 173, 4297-307. https://doi.org/10.4049/jimmunol.173.7.4297
  8. Ibrahim T, Mercatali L, Amadori D (2013). A new emergency in oncology: Bone metastases in breast cancer patients (Review). Oncol Lett, 6, 306-10. https://doi.org/10.3892/ol.2013.1372
  9. Ilkow CS, Swift SL, Bell JC, et al (2014). From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer. PLoS Pathog, 10, 1003836. https://doi.org/10.1371/journal.ppat.1003836
  10. Ito M, Yamamoto S, Nimura K, et al (2005). Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin. J Gene Med, 7, 1044-52. https://doi.org/10.1002/jgm.753
  11. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  12. Kado K, Forsyth A, Patel PR, et al (2012). Dietary supplements and natural products in breast cancer trials. Front Biosci (Elite Ed), 4, 546-67.
  13. Kaneda Y (2003). New vector innovation for drug delivery: development of fusigenic non-viral particles. Curr Drug Targets, 4, 599-602. https://doi.org/10.2174/1389450033490740
  14. Kaneda Y, Nakajima T, Nishikawa T, et al (2002). Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther, 6, 219-26. https://doi.org/10.1006/mthe.2002.0647
  15. Kaneda Y, Yamamoto S, Nakajima T (2005). Development of HVJ envelope vector and its application to gene therapy. Adv Genet, 53, 307-32. https://doi.org/10.1016/S0065-2660(05)53012-8
  16. Kawaguchi Y, Miyamoto Y, Inoue T, et al (2009). Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle. Int J Cancer, 124, 2478-87. https://doi.org/10.1002/ijc.24234
  17. Li P, Nijhawan D, Budihardjo I, et al (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 14, 479-89.
  18. Li Y, Li D, Yuan S, et al (2013). Embelin-induced MCF-7 breast cancer cell apoptosis and blockade of MCF-7 cells in the G2/M phase via the mitochondrial pathway. Oncol Lett, 5, 1005-9. https://doi.org/10.3892/ol.2012.1084
  19. Love RR, Young GS, Laudico AV, et al (2013). Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer. Cancer, 119, 3746-52. https://doi.org/10.1002/cncr.28302
  20. Russell SJ, Peng KW, Bell JC (2012). Oncolytic virotherapy. Nat Biotechnol, 30, 658-70. https://doi.org/10.1038/nbt.2287
  21. Schenk E, Essand M, Kraaij R, et al (2014). Preclinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer. Hum Gene Ther Clin Dev, 25, 7-15. https://doi.org/10.1089/humc.2013.181
  22. Shi LY, Chen J, Zhong QP, et al (2013), Tang H. Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis. J Transl Med, 11, 205. https://doi.org/10.1186/1479-5876-11-205
  23. Shi LY, Li M, Yuan LJ, et al (2008). A new paramyxovirus, Tianjin strain, isolated from common cotton-eared marmoset: genome characterization and structural protein sequences analysis. Arch Virol, 153, 1715-23. https://doi.org/10.1007/s00705-008-0184-9
  24. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, et al (1998). Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell, 14, 949-57.
  25. Strasser A, Cory S, Adams JM (2011). Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J, 30, 3667-83. https://doi.org/10.1038/emboj.2011.307
  26. Tanaka M, Shimbo T, Kikuchi Y, et al (2010). Sterile alpha motif containing domain 9 (SAMD9) is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon. Int J Cancer, 126, 1982-91. https://doi.org/10.1002/ijc.24965
  27. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-62. https://doi.org/10.1126/science.7878464
  28. Wang CZ, Calway T, Yuan CS (2012). Herbal medicines as adjuvants for cancer therapeutics. Am J Chin Med, 40, 657-69. https://doi.org/10.1142/S0192415X12500498
  29. Yamano T, Kaneda Y, Huang S, et al (2006). Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. Mol Ther, 13, 194-202. https://doi.org/10.1016/j.ymthe.2005.05.018
  30. Zhang Q, Li Y, Shi Y, et al (2008). HVJ envelope vector, a versatile delivery system: its development, application, and perspectives. Biochem Biophys Res Commun, 373, 345-49. https://doi.org/10.1016/j.bbrc.2008.06.055
  31. Zhu ZL, Zhang J, Chen ML, et al (2013). Efficacy and safety of Trastuzumab added to standard treatments for HER2-positive metastatic breast cancer patients. Asian Pac J Cancer Prev, 14, 7111-6. https://doi.org/10.7314/APJCP.2013.14.12.7111
  32. Zou X, Liu SL, Zhou JY, et al (2012). Beta-asarone induces LoVo colon cancer cell apoptosis by up-regulation of caspases through a mitochondrial pathway in vitro and in vivo. Asian Pac J Cancer Prev, 13, 5291-8. https://doi.org/10.7314/APJCP.2012.13.10.5291

Cited by

  1. Distinct Pro-Apoptotic Properties of Zhejiang Saffron against Human Lung Cancer Via a Caspase-8-9-3 Cascade vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6075
  2. ALEX1 Regulates Proliferation and Apoptosis in Breast Cancer Cells vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3293
  3. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel vol.22, pp.3, 2015, https://doi.org/10.1038/cgt.2014.74
  4. Effects of Ghrelin on the Apoptosis of Rheumatoid Arthritis Fibroblast-Like Synoviocyte MH7A Cells pp.1347-5215, 2018, https://doi.org/10.1248/bpb.b18-00285